<scp>CXCL</scp> 10 <sup>high</sup> Microglia in Cerebral Malaria: Toward Translational Validation
Wang et al. identify CXCL10<sup>high</sup> TNFα<sup>high</sup> Ki67<sup>+</sup> microglia as drivers of CD8<sup>+</sup> T cell recruitment during experimental cerebral malaria (ECM). We propose a conservative reframing: rather than asserting a fully validated new taxonomy, CXCL10<sup>high</sup> microglia should be considered a candidate "neuroimmune endotype" whose translational relevance requires clearly prespecified and testable validation in human disease. Priority validation steps include single-nucleus and spatial transcriptomics of human postmortem tissue, paired plasma/CSF biomarker correlation, and mechanistic assays of microglial antigen presentation. We caution against strong therapeutic inferences from ECM alone; translational work should first establish reproducible human microglial signatures and clinical correlations before precision-targeted interventions are proposed.
Authors
- Chadaporn Nuchjangreed Gordon
- Nathkapach K Rattanapitoon
- Schawanya K. Rattanapitoon
- Natthawut Charoenphon
Institutions
- Burapha University (TH)
- Maharat Nakhon Ratchasima Hospital (TH)
- Nakhon Ratchasima Rajabhat University (TH)
- Naresuan University (TH)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/cns.70742
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00